Current Affairs   »   Science & Technology Current Affairs 2022   »   India's first locally created HPV vaccine...

India’s first locally created HPV vaccine receives DCGI approval

The Drugs Controller General of India (DCGI) has approved the market authorization of India’s first quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer. The Serum Institute of India (SII) will produce this vaccine. CEO of The Serum Institute of India Adar Poonawalla tweeted the information. For the first time, an inexpensive and widely available HPV vaccination made in India will be available to treat cervical cancer in female patients. Later this year, SII hopes to launch it, and we are grateful to the DCGI, MoHFW INDIA, for their approval.

Buy Prime Test Series for all Banking, SSC, Insurance & other exams

Following an assessment of the clinical trial results for the vaccine, the National Technical Advisory Group on Immunization (NTAGI) recently gave its approval to the qHPV. The Quadrivalent Human Papillomavirus (qHPV) vaccine against cervical cancer, which was produced domestically by Serum Institute of India (SII), was recommended for standard market authorization on June 15. After the vaccine’s phase 3 data were deemed to be satisfactory, suggestions were made.

Important Takeaways For All Competitive Exams:

  • Serum Institute of India’s CEO: Adar Poonawalla

More Sci-Tech News Here

India's first locally created HPV vaccine receives DCGI approval_50.1

India's first locally created HPV vaccine receives DCGI approval_60.1

Thank You, Your details have been submitted we will get back to you.

Leave a comment

Your email address will not be published. Required fields are marked *